肝细胞癌监测 - 使用,障碍和改变病因学的影响
Daniel Q Huang1,2, Amit G Singal3, Fasiha Kanwal4,5
1Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. daniel_huang@nus.edu.sg.
由于意识差距和指导方针限制,肝细胞癌 (HCC) 的监测未得到充分利用. 需要制定战略来改善风险人群的早期检测和治疗,特别是那些患有非酒精性脂肪肝疾病的人.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 公共卫生 公共卫生
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
- 在风险人群中,目前的HCC监测率很低 (<25%).
- 障碍包括有限的认识,知识差距和识别风险患者的挑战.
研究的目的:
- 审查目前HCC监测的现状.
- 确定HCC监测的挑战,包括改变肝病病因.
- 讨论改善HCC监测利用率和质量的策略.
主要方法:
- 关于HCC监测的当前文献的审查.
- 对监控普及障碍的分析.
- 讨论肝病的不断变化的原因及其对监测的影响.
主要成果:
- 存在严重的HCC监测使用不足.
- 非酒精性脂肪性肝病和与酒精有关的肝病是HCC的不断增加的原因,这带来了独特的监测挑战.
- 目前的指导方针可能会错过风险患者,例如那些没有肝硬化而患有非酒精性脂肪肝患者.
- 标准监测方法 (超声波,AFP) 的灵敏度有限,特别是在肝硬化或肥胖患者中.
结论:
- 改善HCC监测需要解决意识,知识和指南的局限性.
- 新策略对于提高HCC监测的有效性和普及至关重要.
- 专注于改变肝病病因对于未来的监测工作至关重要.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
10:35Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
相关概念视频
Hepatic Drug Excretion: Influencing Factors
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Pancreatitis II: Collaborative Care
Assessment:
